Fluid Replacement Versus Fluid Restriction in COVID-19 Associated Hyponatremia
Open Access
- 8 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 12 (7), e9059
- https://doi.org/10.7759/cureus.9059
Abstract
Hyponatremia is one of the most frequently observed electrolyte abnormalities in coronavirus disease 2019 (COVID-19). Literature describes syndrome of inappropriate anti diuretic hormone (SIADH) as the mechanism of hyponatremia in COVID-19 requiring fluid restriction for management. However, it is important to rule out other etiologies of hyponatremia in such cases keeping in mind the effect of an alternate etiology on patient management and outcome. We present a case of hypovolemic hyponatremia in a patient with COVID-19, which unlike SIADH, required fluid replacement early in the disease course for its correction. A 52-year-old Filipino gentleman presented with a three-week history of diarrhea and symptomatic hyponatremia. There was no history of fever or respiratory symptoms. Physical examination revealed a dehydrated and confused middle-aged gentleman. Labs revealed lymphopenia, thrombocytopenia, and severe hyponatremia (108 mmol/L). Blood cultures and stool workup were negative. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nasopharyngeal swab was positive. Hyponatremia workup excluded SIADH. The patient had hypovolemic hyponatremia due to gastrointestinal (GI) losses and was managed with saline infusion for correction of hyponatremia with improvement in his clinical status. Hyponatremia in COVID-19 is not only secondary to SIADH but can also be due to other etiologies. Hypovolemic hyponatremia should be distinguished from SIADH as these conditions employ different management strategies, and early diagnosis and management of hypovolemic hyponatremia affects morbidity and mortality.This publication has 13 references indexed in Scilit:
- ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemiaActa Endocrinologica, 2020
- Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2020
- Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19)Published by Springer Science and Business Media LLC ,2020
- Isolated Bulbar Palsy: A Rare Presentation of NeurosarcoidosisCureus, 2020
- Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United StatesDiagnosis, 2019
- Mortality rates are lower in SIAD, than in hypervolaemic or hypovolaemic hyponatraemia: Results of a prospective observational studyClinical Endocrinology, 2017
- Diagnosis and Treatment of Hyponatremia: Compilation of the GuidelinesJournal of the American Society of Nephrology, 2017
- Effect of Early Correction of Hyponatremia on Neurological Outcome in Traumatic Brain Injury PatientsJournal of Intensive and Critical Care, 2017
- Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-AnalysisPLOS ONE, 2013
- Inflammation and hyponatremia: an underrecognized condition?Korean Journal of Pediatrics, 2013